Satsuma Technology PLC
SATS · Main Market · Consumer Products and Services · mcap £24m · 0.2p
- Revenue
- £11k
- Operating profit
- −£11.2m
- Net income
- −£26.3m
- Free cash flow
- −£36.2m
- Net cash
- £8.8m
- Market cap
- £23.5m
- EV / EBIT
- –
- FCF yield
- −154.0%
- Price / book
- –
- Revenue
- £10k prior £0k
- Operating profit
- −£10.9m prior −£383k
- Net income
- −£25.9m prior −£383k
- Cash from operations
- −£1.9m prior −£247k
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
The statement exactly as printed in one results announcement – its own columns (the period and its comparatives), lines and headings, in the company's currency and units. Choose the report above; to compare several years, use Key figures.
Standardised line items in £m, comparable across companies; when a later report restated a period, the later figure is shown and marked r (hover for the figure first reported). Italic = calculated (LTM, H2 = FY − H1); a year of other than 12 months is marked (15m). Hover a value for its source.
Latest report: FY Feb 26 (twelve months to 28 Feb 26), published 17 Sep 26 · read the results ↗
| Non-Current Assets | ||||
| Intangible assets | 30,832 | 45 | 255 | 45 |
| Investments | 1,413 | 250 | 1,413 | 250 |
| Investments in subsidiary | - | - | 31,806 | - |
| Total Non-Current Assets | 32,245 | 295 | 33,474 | 295 |
| Current Assets | ||||
| Trade and other receivables | 150 | 25 | 150 | 25 |
| Cash and cash equivalents | 8,775 | 31 | 6,848 | 31 |
| Total Current Assets | 8,925 | 56 | 6,998 | 56 |
| Total Assets | 41,170 | 351 | 40,472 | 351 |
| Current Liabilities | ||||
| Trade and other payables | 1,135 | 464 | 14,119 | 464 |
| Restructuring Provision | 1,457 | - | 757 | - |
| Total Current Liabilities | 2,592 | 464 | 14,876 | 464 |
| Total Liabilities | 2,592 | 464 | 14,876 | 464 |
| Net Assets/(Liabilities) | 38,578 | (113) | 25,596 | (113) |
| Equity attributable to owners of the Parent | ||||
| Share capital | 11,204 | 454 | 11,204 | 454 |
| Share premium | 86,105 | 4,880 | 86,105 | 4,880 |
| Warrant reserve | 15,051 | 743 | 15,051 | 743 |
| Revaluation reserve | - | 45 | - | 45 |
| Foreign currency translation reserve | 98 | - | - | - |
| Retained losses | (73,880) | (6,235) | (86,764) | (6,235) |
| Total Equity | 38,578 | (113) | 25,596 | (113) |
| Cash flows from operating activities | ||
| Loss before income tax | (76,914) | (707) |
| Adjustments for | ||
| Revenue received in intangible assets | (42) | - |
| Revaluations of intangible assets | - | 45 |
| Unrealised loss on intangible assets | 25,881 | - |
| Loss on disposal of intangible assets | 6,763 | - |
| Fair value gains on investments | (1,163) | - |
| Fair value loss on derivative liabilities | 9,446 | - |
| Loss on CLN settlements received in Bitcoin | 2,142 | - |
| Effective interest charge on convertible loan notes | 21,212 | - |
| Non-cash warrants expense | 1,038 | 39 |
| Impairment of social security and other taxation balance | 895 | - |
| Operating expenses settled through warrants | 110 | - |
| Unrealised foreign exchange losses | 604 | - |
| (Increase)/Decrease in trade and other receivables | (1,020) | 30 |
| Increase in trade and other payables | 987 | 279 |
| Increase in provisions | 1,457 | - |
| Net cash used in operating activities | (8,604) | (314) |
| Cash flows from investing activities | ||
| Purchase of intangible assets | (27,556) | (45) |
| Disposal proceeds from sale of intangible assets | 59,025 | - |
| Purchase of investments | - | (250) |
| Foreign exchange difference on disposal proceeds | (272) | - |
| Net cash generated from/(used in) investing activities | 31,197 | (295) |
| Cash flows from financing activities | ||
| Proceeds from issue of share capital | 948 | 75 |
| Proceeds from issue of convertible loan notes | 64,903 | - |
| Repayments of convertible loan notes | (77,971) | - |
| Convertible loan note transaction costs paid | (1,699) | - |
| Net cash (used in)/generated from financing activities | (13,820) | 75 |
| Net increase/(decrease) in cash and cash equivalents | 8,773 | (534) |
| Cash and cash equivalents at beginning of year | 31 | 565 |
| Effect of foreign exchange rate changes on cash and cash equivalents | (29) | - |
| Cash and cash equivalents at end of year | 8,775 | 31 |
| Period ending 31 August 2025 £'000 | Period ending 31 August 2024 £'000 | Year ending 28 Feb 2025 £'000 | |
|---|---|---|---|
| Continuing Operations | |||
| Revenue | 10 | - | 1 |
| Cost of Sales | - | - | - |
| Gross Profit | 10 | - | 1 |
| Administrative expenses | (2,110) | (383) | (709) |
| Revaluation loss on cryptocurrencies | (8,822) | - | - |
| Operating loss | (10,922) | (383) | (708) |
| Finance Costs | (2,899) | - | - |
| Fair value loss on derivative financial instruments | (11,583) | - | - |
| Foreign Currency (loss) | (531) | - | - |
| Loss before taxation | (25,935) | (383) | (708) |
| Taxation on loss of ordinary activities | - | - | - |
| Loss for the period from continuing operations | (25,935) | (383) | (708) |
| Other comprehensive income | (24) | - | - |
| Total comprehensive loss for the period attributable to shareholders from continuing operations | (25,959) | (383) | (708) |
| Basic loss per share ( pence) | (5.49) | (0.10) | (0.18) |
| Diluted loss per share (pence) | (1.14) | (0.10) | (0.18) |
| 31 August 2025 | 31 August 2024 | 28 Feb 2025 | |
|---|---|---|---|
| Company No. | 13279459 | – | – |
| Unaudited Unaudited | |||
| NON-CURRENT ASSETS | |||
| Intangible assets | 92,489 | - | 45 |
| Investments | - | - | 250 |
| Investments - Held for Sale | 250 | - | - |
| TOTAL NON-CURRENT ASSETS | 92,739 | - | 295 |
| CURRENT ASSETS | |||
| Cash and cash equivalents | 60,554 | 318 | 31 |
| Trade and other receivables | 143 | 32 | 25 |
| TOTAL CURRENT ASSETS | 60,697 | 350 | 56 |
| TOTAL ASSETS | 153,436 | 350 | 351 |
| EQUITY | |||
| Share capital | 528 | 379 | 454 |
| Share Premium | 6,020 | 4,880 | 4,880 |
| Warrants Reserve | 426 | 704 | 743 |
| Revaluation Reserve | 21 | - | 45 |
| Other reserves | 30 | - | - |
| Convertible loan note reserve | 7,852 | - | - |
| Retained Earnings | (31,853) | (5,910) | (6,235) |
| TOTAL EQUITY | (16,976) | 53 | (113) |
| CURRENT LIABILITIES | |||
| Trade and other payables | 2,707 | 297 | 464 |
| Convertible Loan Note 1 | 4,876 | - | - |
| Convertible Loan Note 2 | 151,246 | - | - |
| TOTAL CURRENT LIABILITIES | 158,829 | 297 | 464 |
| NON-CURRENT LIABILITIES | |||
| CLN 1 - Seed Warrants Derivative Liability | 10,313 | - | - |
| Broker Warrants - Derivative Liability | 1,270 | - | - |
| TOTAL LIABILITIES | 170,412 | 297 | 464 |
| TOTAL EQUITY AND LIABILITIES | 153,436 | 350 | 351 |
| Period ending 31 August 2025 £'000 | Period ending 31 August 2024 £'000 | Year ending 28 Feb 2025 £'000 | |
|---|---|---|---|
| Cash flows from operating activities | |||
| Loss for period | (25,959) | (383) | (707) |
| Adjustments for | |||
| Impairment | - | - | 45 |
| Revaluation loss on cryptocurrencies | 8,846 | - | - |
| Services settled by issue of warrants | 266 | - | 39 |
| Finance Costs (non-cash unwinding of CLN discount) | 2,899 | - | - |
| Fair value loss on derivative financial instruments | 11,583 | – | – |
| Changes in working capital | |||
| (Increase)/Decrease in trade and other receivables | (118) | 23 | 30 |
| Increase in trade and other payables | 543 | 113 | 279 |
| Net cash used in operating activities | (1,940) | (247) | (314) |
| Cash flows used in investing activities | |||
| Purchase of intangible assets | (4,500) | - | (45) |
| Investments | - | - | (250) |
| Net cash flows used in investing activities | (4,500) | - | (295) |
| Cash flows from financing activities | |||
| Share issue, net of issue costs | 973 | - | 75 |
| Cash proceeds from Issue of Convertible Loan Notes | 66,035 | - | - |
| Net cash flows generated from financing activities | 67,008 | 25 | - |
| Net increase/( decrease) in cash and cash equivalents | 60,568 | (247) | (534) |
| Cash and cash equivalents at beginning of the period | 31 | 565 | 565 |
| Foreign exchange impact on cash | (45) | - | - |
| Cash and cash equivalents at end of the period | 60,554 | 318 | 31 |
| H2 Feb 26 | H1 Aug 25 | H2 Feb 25 | H1 Aug 24 | |
|---|---|---|---|---|
| Revenue to operating profit | ||||
| Revenue | – | 0.0 | 0.0 | 0.0 |
| Operating profit | – | (10.9) | (0.3) | (0.4) |
| Operating profit to net income | ||||
| Finance costs | – | (2.9) | – | – |
| Profit before tax | (51.0) | (25.9) | (0.3) | (0.4) |
| Net income (owners) | – | (25.9) | (0.3) | (0.4) |
| Per share | ||||
| EPS basic | – | (5.5p) | (0.1p) | (0.1p) |
| EPS diluted | – | (1.1p) | (0.1p) | (0.1p) |
| 28 Feb 26 | 28 Feb 25 | |
|---|---|---|
| Non-current assets | ||
| Other intangibles | – | 0.0 |
| Non-current assets | – | 0.3 |
| Current assets | ||
| Trade receivables | – | 0.0 |
| Cash | 8.8 | 0.0 |
| Current assets | – | 0.1 |
| Total assets | – | 0.4 |
| Current liabilities | ||
| Trade payables | – | 0.5 |
| Current liabilities | – | 0.5 |
| Non-current liabilities | ||
| Non-current liabilities | – | 0.0 |
| Total liabilities | – | 0.5 |
| Equity | ||
| Total equity | – | (0.1) |
| 28 Feb 26 | 31 Aug 25 | 28 Feb 25 | 31 Aug 24 | |
|---|---|---|---|---|
| Non-current assets | ||||
| Other intangibles | – | 92.5 | 0.0 | – |
| Non-current assets | – | 92.7 | 0.3 | 0.0 |
| Current assets | ||||
| Trade receivables | – | 0.1 | 0.0 | 0.0 |
| Cash | 8.8 | 60.6 | 0.0 | 0.3 |
| Current assets | – | 60.7 | 0.1 | 0.3 |
| Total assets | – | 153.4 | 0.4 | 0.3 |
| Current liabilities | ||||
| Trade payables | – | 2.7 | 0.5 | 0.3 |
| Current liabilities | – | 158.8 | 0.5 | 0.3 |
| Non-current liabilities | ||||
| Non-current liabilities | – | 11.6 | 0.0 | 0.0 |
| Total liabilities | – | 170.4 | 0.5 | 0.3 |
| Equity | ||||
| Total equity | – | (17.0) | (0.1) | 0.1 |
Read automatically from each results announcement. Check the source before relying on a figure.
Spotted an error in this income statement? Report it
Company filings. Not investment advice.